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ABSTRACT 
 
Developmental robustness and redundancy are properties of biological systems that 
facilitate adaptation and survival in stressful environments. Through use of novel screens for 
synthetic phenotypes, we have elucidated a fascinating interaction between miRNAs and Vigilin, 
an RNA binding protein predicted to have a variety of different cellular functions within 
development. Synthetic screening indicates that mir-52, mir-59, mir-83, mir-254, and mir-265 all 
interact redundantly with Vigilin to modulate larval progression. Computational analysis and 
further RNAi testing yielded a list of potential downstream targets that these miRNAs might 
regulate to control development in a complex and robust manner. RT-qPCR and genetics will be 
used to study these potential targets to provide further insight into the interactions between 
miRNAs and Vigilin with the overarching goal of gaining a better understanding of development 
within C. elegans. 
INTRODUCTION 
 
Developmental Robustness and Redundancy 
 
Within animal and plant cells, there are numerous regulatory pathways that modulate 
when, where, and how much of a certain protein is produced and to what extent a gene is 
expressed. In recent years many of these pathways have been discovered to work together in a 
redundant fashion in order to dictate when and where a cell will reach a certain fate. In any 
organism there are numerous different pathways, cell types, signaling molecules, organ systems, 
and the like that all work together to craft the organism as a whole. Central to the study of 
molecular and developmental biology is ascertaining when, why, and how these various systems 
work together on the most basal levels to shape functions on the macro level. 
	  	  
The early developmental biologist C. H. Waddington described development as a bunch 
of marbles rolling down a hill towards a wall (Van Speybroeck, 2002). As each marble rolls 
down, it has the potential to fall into any sort of canal, crevice, canyon, or, as Waddington 
coined, “creode” that lines the path down the hillside. The marbles will compete for the grooves 
in the path and will all attempt to settle at the lowest point of the hill (the wall). The time and 
way they get to the bottom, however, is vastly different between the marbles depending on their 
timing (e.g. if they were released sooner or later than other marbles) and path. Waddington called 
this crevice-riddled landscape the “epigenetic landscape,” referring to the factors and 
mechanisms outside genetic material that regulate why an organism takes on a certain fate over 
other fates. 
While all cells take a different “path” down the hill, all of the cells must reach the 
bottom at some point—and more often that not a lot of these “paths” meld together, or level out. 
In this idea, Waddington presented the idea of robustness—the idea that a number of systems and 
conditions (a number of different grooves down the hill) work together redundantly to ensure the 
final fitness of an organism. While superficially rolling marbles down a hill seems like a random 
process, in actuality it is modulated and regulated by a number of different physical factors like 
gravity—that is to say each marble has a set trajectory. In biology the same is true. Each cell’s 
“roll down that hill” while seemingly unique and independent is precisely regulated at each and 
every turn down that hill. The idea of redundancy causing robustness, is that even if one of these 
marbles misses a certain canal, there are other redundant canals available for it to take, all 
leading to the same final position, ensuring robustness. Similarly an organism trying to maintain 
evolutionary fitness also has a number of systems to ensure robust development and survival. 
 
	  	  
MicroRNA and the miRISC 
One regulatory pathway that contributes to developmental robustness involves micro-
ribonucleic acid, or MicroRNA. The Han lab has studied the functions of these small RNA 
molecules for nearly two decades. 
MicroRNA (abbreviated miRNA) are small, 22 to 23 nucleotide long RNA molecules 
that act to protect cells by managing when and where certain proteins are produced. To achieve 
this goal, the miRNA binds to the end of a target messenger RNA in the 3’ untranslated region 
and either prevents the translation of that messenger RNA into a protein or degrades the 
messenger RNA (Lim et al., 2005; Bagga et al., 2005, Bartel et al., 2009). These miRNAs 
accomplish this substantive feat through interactions with a set of RNA binding proteins that 
bind to the miRNA. Collectively, this combination of miRNA and RNA binding proteins is 
known as the microRNA Induced Silencing Complex, or the miRISC. Selective gene silencing, a 
mechanism used by the cell to stop a gene being transcribed or translated, is a vital function in 
all cells that enables cells with the exact same set of DNA to do strikingly different things. 
miRNAs are transcribed in similar fashion to normal mRNAs, however after 
transcription they form a double stranded hairpin-loop structure with themselves and are 
processed by a number of proteins (known as the microprocessor complex in humans) within the 
nucleus to produce a pre-miRNA. This pre-miRNA is then exported out of the nucleus by 
another set of proteins. After it’s exodus to the cytoplasm a pre-miRNA is then processed into its 
final form by an endoribonuclease, Dicer, and a number of other proteins that lead to a mature 
single-stranded miRNA (Lund and Dahlberg 2006). This single-stranded miRNA then localizes 
with the miRISC to promote gene silencing of a target by mRNA destabilization or translational 
blockage.
	  	  
 
 
 
Figure 1: Processing of nascent miRNA (Winter et al., 2009). 
 
The microRNA Induced Silencing Complex (miRISC) is a complex of ribonucleotide 
binding proteins that function together to facilitate miRNA silencing of a target gene. The 
complex consists of a microRNA bound to argonaute proteins (ALG-1 and ALG-2 in C. 
elegans), bound to GW182 which is in turn bound to a number of other proteins that assist in 
silencing (Hafner et al., 2011, Tritschler et al., 2010, Zhang et al., 2005). Within C. elegans, 
AIN-1 and AIN-2 are homologous to GW182. Ain-1 has been shown to interact with worm 
argonaute homologs in a similar fashion to the human proteins (Ding and Han, 2005). MiRNA 
function is reduced when ain-1 or ain-2 are knocked out; when both are knocked out in tandem it 
results in a lethal phenotype. 
	  	  
 
 
 
Figure 2: miRISC Function and Group Members (Modified from Fabian et al., 2012) 
 
MicroRNAs are conserved in higher organisms, and mutated miRNAs have been 
indicated as possible contributing factors in a variety of different human diseases including 
numerous forms of cancers (Malumbres et al., 2013, Pereira et al., 2013). MicroRNAs function 
in “families,” such that the loss of one miRNA is often not deleterious as other family members 
make up for its loss of function with a similar activity, binding site, and purpose (Alvarez- 
Saavedra et al., 2010). This redundancy within the miRISC provides a fascinating glimpse into 
the system of robustness that has developed among higher organisms. However, it has 
additionally made the study of miRNA difficult (as single miRNA knockouts often result in no 
phenotype) so the specific role of many miRNAs remains unknown or clouded. Deleting entire 
families of miRNAs further revealed that many families are not essential for development or 
viability (Alvarez-Saavedra et al., 2010). This led the lab to hypothesize that miRNAs function 
redundantly with other gene regulation mechanisms. 
	  	  
Genome-wide Screen for Developmentally Vital Genes 
 
Within the Han lab, a genome-wide screen was completed that was searching for genes 
that become essential for development when miRISC function was reduced (Weaver, Zabinsky, 
et al., 2014). To complete this screen, Post-docs Ben and Yi Weaver and Ph. D. student Rebecca 
Zabinsky plated ain-1(lf) and ain-2(lf) worms on the RNAi of genes from the ORF RNAi library. 
The loss of ain-1 and ain-2 together (that is ain-1(-); ain-2(-)) results in a lethal phenotype within 
worms (due to non functional miRNAs); however, single mutants of either ain-1 or ain-2 results 
in only a minor developmental timing defect. The ain-1(-); ain-2(-) phenotype is an example of a 
synthetic phenotype: a phenotype that is observed when two genes are knocked out in tandem 
but not observed when knocked out individually. Within this synthetic screen, worms were 
scored for any abnormal phenotypes that were seen in the ain-1/2 worms on RNAi, but not 
observed on ain-1/2 worms on empty vector RNAi. Any phenotypes observed by this method are 
known as synthetic, since deletions in the genes by themselves result in little observable 
phenotype but deletion of both results in a severe phenotype. 
Vigilin 
 
One of the many interesting genes identified in this screen was vgl-1 (vigilin). When 
ain-2 worms were plated on vgl-1 RNAi, a 90% larval (L1) arrest phenotype was observed. Vgl- 
1 is a member of a family of RNA binding proteins proposed to have roles in a number of 
cellular processes including telomeric silencing, tRNA splicing, heterochromatin formation, and 
cholesterol export (Kügler et al., 1996, McKnight et al., 1992, Vollbrandt et al., 2004,Woo et al., 
2011, Yang et al., 2014). In humans loss of vigilin function has been observed to contribute to 
proliferation in several cancers  (Woo et al.,2011, Molyneux et al., 2014). However, the
	  	  
exact role and function of vigilin remains difficult to pin down and identifying an interaction with 
the miRISC is a novel result. 
Vigilin was first identified and studied within chickens in the 1990s. Early studies 
suggested that vigilin (known as High Density Lipoprotein Binding Protein, or HDLBP, in 
humans) functioned to modulate cholesterol export by binding High Density Lipoprotein within 
cells. Additionally, vigilin weighs 150 kD, has 15 KH-binding domains that enable vigilin to 
bind to RNA (Kügler et al., 1996), has a nuclear localization signal (Kügler et al., 1996), is 
found in nearly all cells both cytoplasmically and in the nucleus, and is heavily conserved in a 
variety of different organisms. More recently vigilin has been shown to bind ribosomal proteins 
(Vollbrandt et al., 2004) and interact with signal peptide peptidase (Lu et al., 2012). Despite the 
current research on vigilin identifying these numerous functions and characteristics of the 
protein, the functional identity of vigilin still remains open to debate and elucidating the overall 
purpose of vigilin is an interesting mystery within development. 
The purpose of this study was to examine this observed novel interaction between vigilin, 
the miRISC, and predicted downstream targets within C. elegans to identify how these 
interactions are modulating gene expression and perhaps provide clarity on vigilin’s function 
within development. To study this interaction, a combination of methods was used. A synthetic 
screen for miRNA(-) single mutants on vigilin RNAi was performed to identify which specific 
miRNAs are contributing to the synthetic larval arrest phenotype. From here, crosses were 
carried out to confirm any observed phenotypes. Next, through the use of a variety of methods 
and databases a list (and then a second list) of predicted downstream targets was compiled and 
tested for any efficacy in suppressing the larval arrest phenotype. To identify specific targets 
contributing to the larval arrest phenotype, qRT-PCR was used to quantify expression 
	  	  
differences of the predicted miRNA target gene T24B8.5 in miRNA mutant worms and vigilin 
mutant worms. Together these methods provide novel insights into the role of vigilin and 
specific miRNAs in development. 
 
 
METHODS 
 
General C. elegans Strain Maintenance 
 
C. elegans strains used were either obtained from the CGC or from the Han Lab’s frozen 
stocks. Strains were maintained and picked weekly to remove contamination and prevent 
starvation. Strains were stored at 20oC unless otherwise noted. A list of strains used is attached 
(supplemental table 1). 
miRNA(-) worms on Vigilin RNAi 
 
To test for specific miRNA mutants contributing to the larval arrest phenotype observed 
in ain-2(-); vgl-1(-) worms, a list of the miRNAs identified within C. elegans was compiled, 
single mutant strains were unfrozen or ordered from the CGC from this list, and these single 
mutants were allowed to lay eggs on RNAi plates. The protocol for screening each single mutant 
is as follows: 
Day 1: Inoculate cultures of vgl-1 RNAi and empty vector (control) RNAi. 
 
Day 2: Inoculate cultures of vgl-1 RNAi and empty vector (control) RNAi, using cultures from 
previous day. Incubate for 4 hours and then spot onto to IPTG+AMP plates. 
Day 6: 3 larval-4 stage miRNA-“X”(-) worms were picked to a single vgl-1 RNAi plate. 3 larval- 
4 stage miRNA-X(-) worms were picked to a mock RNAi plate. 
Day 7: After 24 hours adult worms were singled to new RNAi plates. 
Day 8: After 24 hours, gravid adults were flamed. 
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Day 10: F1 generation of worms were scored for larval arrest. The number of larval worms 
(errant phenotype) and adult worms (normal phenotype) were then compared. 
This screen was completed for each of the 88 miRNA strains obtained. 
 
miRNA(-) and vgl-1 Crosses 
 
miRNA(-) single mutants with a larval arrest phenotype (observed in the screen above) 
on vgl-1 RNAi were crossed to vgl-1(-) worms to confirm the phenotype was not just an artifact 
of the RNAi feeding. NT1, a well-published balancer, was used to balance the strains throughout 
the crosses. Genotyping by PCR confirmed the genotype of the worms. These crosses are still in 
progress at time of writing. 
miRNA Predicted Target Analysis—Pilot Analysis 
 
The predicted targets of miRNAs identified in the miRNA on vgl-1 RNAi synthetic 
screen were compiled from the databases of mirbase (mirbase.org), target scan (targetscan.org), 
wormbase (wormbase.org), and pubmed (ncbi.nlm.nih.gov/pubmed). The compiled database 
contained data for every miRNA family in C. elegans and contained roughly 1,000,000 rows of 
data. From this set, predicted targets of the miRNAs identified in the synthetic screen with a 
6mer, 7mer, or 8mer binding predicted binding site were selected, screened for duplicates (per 
each miRNA), and then compared to miRNA targets enriched in a neuronal IP, a L1 IP, and a 
egg IP (all studies performed earlier within the Han lab, Zhang et al. 2009, Kudlow et al. 2011, 
Than et al. 2012). This narrowed the list down to roughly 20,000. Worm mine 
(wormbase.org/tools/wormmine), a data mining tool, was then used to convert the data to an 
easily usable format and create a final predicted target list for each miRNA identified as 
contributing to the larval arrest phenotype in the synthetic screen. The final list of predicted 
targets was roughly 500 genes. From here, Venny (bioinfogp.cnb.csic.es/tools/venny/) was used 
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to compare the list of targets for each miRNA, looking for common predicted targets shared 
between miRNAs. This list had roughly 50 genes. 
ain-2(-); vgl-1(-) Worms on RNAi of Predicted Targets 
 
The RNAi of each of the 50 gene targets found by the protocol described above were 
obtained through the Ahringer and ORF RNAi libraries. The same protocol that was used for the 
miRNA single mutants on vigilin RNAi was conducted with these RNAi strains. Heterozygous 
HT2(with a GFP marker)/ain-2(lf); vgl-1(lf) worms were picked to the RNAi of these predicted 
targets and the F2 generation was scored for rescue. Progeny with homozygous ain-2(lf) are 
expected to have a 90% larval arrest phenotype when paired with a homozygous loss of function 
of vgl-1. In comparison, worms that keep the HT2 marker will show little to no arrest at the 
larval stage. Accordingly without rescue, a ratio of 1:25 Non-GFP:GFP worms is expected on the 
RNAi. The presence of a ratio different from this indicates the possibility that a suppression of 
the larval arrest has occurred. 
miRNA Predicted Target Analysis—Second Round 
 
A second round of miRNA target analysis was completed using data from TarBase and 
miRWip rather than the sources listed earlier. A list of 350 predicted miRNA targets was 
compiled and compared to enriched targets in a Dicer microarray (Welker et al., 2007 ) and 
enriched hits from an IP of a intestine promoter, ges-3 (Kudlow et al. 2011). Results were 
visualized with Venny like before, and similar target analysis is planned. 
GoTerm Analysis 
 
Targets from this second list were then compared to a list of every gene in the C. elegans 
 
genome (list retrieved from wormbase) using Babelomics (Al-Shahrour et al., 2004), 
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according to the Fatigo algorithm. GoTerms are a standardized list of descriptors ascribed to 
genes for specific functions. 
 
 
RESULTS 
 
Ain-2(lf) worms on Vigilin RNAi 
 
Ain-2(-) worms on vigilin RNAi produced a L1 arrest phenotype of 90% (Fig. 1), similar 
to results observed previously in the Han Lab 
 
 
Figure 3: proportion larval arrest of wild type and ain-2 worms on vigilin RNAi. Error Bars represent standard error of 
proportion. P<<0.05 according to a Fischer’s Exact P Test. 
 
miRNA Single Mutants on Vigilin RNAi 
 
Systematic analysis of 88 miRNA single mutant worms on vigilin RNAi in C. elegans 
found that over half of the strains tested contribute statistically significantly to the larval arrest 
phenotype as is expected according to the redundancy of miRNAs (Fig. 4). Values above 8% are 
significant according to a Fischer’s Exact P Test. 
Proportion	  Larval	  Arrest	  on	  vigilin	  RNAi	  	  0.9	  0.8	  0.7	  0.6	  0.5	  0.4	  0.3	  0.2	  0.1	  	  
n	  =	  583	  
n=	  1096	  
N2	  (wild	  type)	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Figure 4: miRNA(-) single mutants on vigilin RNAi. Error bars represent standard error of proportion. Values above 8% 
have a P value of <0.05 according to a Fischer’s Exact P Test. 
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Strains that had a larval arrest phenotype of >20% were considered “extremely 
significant” and useful for further procedures. Of the miRNA mutants tested, mir-35-41(-), mir- 
52(-), mir-58(-), mir-59(-), mir-83(-), mir-254(-), mir-265(-), and mir-61(-); mir-250(-) worms 
all produced an extremely significant L1 arrest phenotype on vigilin RNAi with p <0.00001 
using a Fischer’s Exact P-Test (Fig. 5). 
 
Figure 5: miRNA(-) mutants with elevated L1 arrest on vigilin RNAi. Error bars represent standard error of proportion. 
 
miRNA Predicted Targets and Results (Pilot Analysis) 
 
miRNA(-) single mutant strains with an elevated larval arrest phenotype of more than 
25% on vigilin RNAi were analyzed using the methods listed above for potential targets. 
Accordingly, miRNA-35-41(-), miRNA-59(-), miRNA-83(-), miRNA-254(-), mir-265(-), and 
miRNA-52 were examined for potential targets using miRbase and targetscan for a base list of 
hits. This list for each miRNA was then compared to enriched targets in an L1 IP, neuronal IP, 
and egg IP done previously and common targets between each subset were selected for further 
examination (example 1). 
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Example 1: Comparison of mir-83 predicted targets to targets enriched in various IPs. This was performed for each 
miRNA. 
 
A final list of filtered targets (those predicted to be targeted by a miRNA mutant and 
enriched in one or more IPs) was assembled in this way, creating a final list of 346 genes (sup. 
table 2) from the initial list of over 5000. The predicted function of these genes (from the 
Ahringer RNAi library “suspected function” column) was compiled and compared (Fig. 6). 
 
 
 
Figure 6: Numbers and percentages of  miRNA targets' predicted functions. 
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Additionally, the predicted targets of each miRNA on this final list were then compared 
to each other (Example 2) for common hits. 
 
Example 2: Comparison of predicted miRNA targets between multiple miRNAs. This was performed for all miRNAs 
identified in the synthetic screen as extremely significant to the larval arrest phenotype. 
 
This analysis resulted in a list of 53 predicted targets regulated by 2 or more miRNA (Table 1). 
 
 
Sequence Gene Name  Number of miRNA 
predicted to be targeted by 
 
R10E12.2 	   4 
Y38F1A.5 ddl-3 4 
C01C7.1 madf-5 3 
F07C3.4 adt-2 3 
F13D11.2 lips-10 3 
F13H6.1 acy-1 3 
H13N06.2 	   3 
K08H10.4 	   3 
B0410.3 	   2 
B0464.4 bre-3 2 
B0464.4 ark-1 2 
C01G12.1 swt-3 2 
C06G8.1 nas-7 2 
C07D10.4 	   2 
C13B4.1 dyci-1 2 
C17H12.1 anat-1 2 
C17H12.13 cab-1 2 
C23H4.1 	   2 
C26B9.1 	   2 
C30F12.2 	   2 
C34B2.11 lon-2 2 
C39E6.1 	   2 
C53B4.3 nhr-19 2 
E02H1.7 glo-4 2 
F07C3.4 hbl-1 2 
F08C6.1 	   2 
F14E5.5 	   2 
F17C8.1 egl-1 2 
F18C5.10 snb-2 2 
F23B12.9 cdh-4 2 
F23H12.1 rgl-1 2 
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F25F2.2 	   2 
F28B4.2 vha-5 2 
F29B9.8 wrt-3 2 
F35H10.4 dep-1 2 
F38E11.7 swan-2 2 
F44G4.8 	   2 
F53C11.7 	   2 
F59B2.2 	   2 
H10E21.5 ser-3 2 
K02F2.6 uda-1 2 
K08E3.4 erv-46 2 
K09E9.2 msi-1 2 
R10E9.1 tlp-1 2 
T23B12.6 	   2 
T23G4.1 snf-1 2 
T28D6.4 vab-2 2 
W03G9.1 tcl-2 2 
Y37E11AR.6 cyd-1 2 
Y38C1AA.4 rig-4 2 
Y42H9B.2 lron-11 2 
Y54G11A.8 	   2 
Y71F9B.8 	   2 
 
Table 1: list of predicted targets regulated by more than one miRNA identified in the synthetic screen. 
 
To test if any of these 53 genes are contributing to the larval arrest phenotype, ain-2(-);vgl-1(-) 
worms were plated on RNAi of each of the targets from table 2 to observe if knockout of these 
predicted targets can suppress the larval arrest, however no statistically significant suppression 
was observed. 
miRNA Predicted Target Analysis (Second Round) 
Following the analysis of the first data list, a second list of downstream potential miRNA 
targets was compiled using similar but refined methods to those used above. Predicted targets of 
miR-52, miR-59, miR-83, miR-254, and miR-265 were compiled using recent data from 
miRWip (Hammell et al., 2006) and TarBase (Vlachos et al., 2014), creating a list of roughly 
550 targets. Predicted targets from the mirWIP list were only considered if identified in an Ain-2 
or Alg-1 IP. This list was then compared to a list of mRNAs that are increased in a Dicer mutant 
(Welker et al., 2007). Additionally, the initial list was compared to enriched targets in a Pges-
1:Ain-2 IP, because it was found that intestine specific ain-2 expression can somewhat suppress 
the larval arrest phenotype within the double mutant. The comparison is shown below (Figure 7). 
This list was then compared to the list compiled in the pilot analysis (Figure 8). 
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Figure 7: Comparison of Raw list of predicted miRNA targets (blue), Intestine IP enriched targets (yellow), and enriched 
targets from the Dicer IP (green). 
 
 
 
Figure 8: Comparison of Old miRNA predicted targets (from the pilot screen) to the "new" list of potential hits. List of 
targets within each segment of the diagram are found in supplemental table 3. 
This list of final targets and their commonalities with the Intestine IP, Dicer mutant, and old  
 
targets is attached (supplemental table 3). 
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GoTerm Analysis 
 
GoTerm analysis was completed for this new list of targets, computing significant 
(according to a Fischer’s P test) differences between terms identified with the compiled gene list 
and a control gene list of all the genes in the C. elegans genome (list of genes taken from 
Wormbase). Comparisons of significant GoTerms by percentages are shown below for biological 
function, molecular function, and cellular components (Figure 9). Each comparison compares the 
percentage of the potential list of targets (“Experimental Gene List Percentage”) to the 
percentage in overall genome (“Control List Percentage”). 
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Figure 9: GoTerms with significant (p<0.05) enrichment. Chart A represents biological process GoTerm enriched 
differences, Chart B represents molecular function GoTerm enriched differences, and Chart C represents cellular 
component enriched term differences. 
 
Assorted Other RNAi Results 
In addition to the miRNA(-) on vgl-1 RNAi screen that was completed, a number of other 
synthetic screens were completed with candidate genes we hypothesized might be synthetic 
either with vgl-1 or ain-2. Notably, the insulin pathway was screened for potential interactions 
due to the known role of insulin signaling in dauer and larval arrest formation (Fig. 10). 
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Figure 10: vgl-1(-) worms on insulin pathway RNAi. Error bars represent standard error of proportion. 
 
Additionally, a number of other interesting genes known to contribute to development were also 
screened (Fig. 11). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: ain-2(-) and vgl-1(-) worms on various RNAi. Here “CO8” refers to vigilin RNAi. Error bars represent 
standard error of proportion. 
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DISCUSSION 
 
Based upon the data presented in figure 4 in the miRNA and vgl-1 synthetic screen, it is 
likely that many microRNAs act redundantly in parallel with Vigilin to modulate development 
within C. Elegans. The fact that so many of the screened miRNAs contributed to the phenotype 
is consistent with the redundancy of microRNAs. Additionally, the high number of significant 
strains could indicate sensitivity to the RNAi; however the large range of larval arrest between 
significant strains makes RNAi sensitivity likely not the only causative factor for the larval arrest 
phenotype. This issue of RNAi sensitivity will be addressed once crosses of the highly 
significant (>20% larval arrest) miRNAs with vgl-1(-) are complete, but this is still in progress. 
Of the microRNAs that produced a phenotype of greater than 20% larval arrest, mir-52, 
mir-59, mir-83, mir-254, and mir-265 seem to be the most reliable for future study. The mir-35 
family, while producing an extremely significant larval arrest phenotype, has been already shown 
to have some deleterious effects on development and has been shown to be sensitive to RNAi. 
Additionally initial results were misleading, as further testing of both strains used to test the 
miR-35 family produced varying degrees of embryonic lethality, indicating a possible sensitivity 
to the RNAi. Of the 5 remaining targets, miR-254 and miR-52 are conserved while miR-59, 
miR-83, and miR-265 are not. Mir-254 is homologous to human miR-19, a miRNA indicated in 
a number of cancers. Of the other four targets, little study has been done and their overall 
function remains unknown, so the results postulated here present an interesting link between 
these miRNA and early development within C. elegans. 
The pilot target analysis of each of the miRNAs individually and in comparison to each 
other and various microarrays and immunoprecipitation data has yielded a list of potential 
downstream targets whose misregulation might be contributing to this larval arrest phenotype. 
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Further analysis, in the form of tests to see if the RNAi of these targets can suppress the larval 
arrest phenotype, remain to be done as presented methods of testing HT2/ain-2(-); vgl-1(-)/vgl(-) 
remain somewhat ineffective as the double mutant is extremely sick, making screens difficult. 
Testing with the less ill miRNA-“X”; vgl-1(-) crosses might yield better and more conclusive 
results and should be easier to screen. It is expected, according to the general mechanism of 
miRNA action, that the larval arrest phenotype is induced by a number of misregulated 
downstream targets acting together so any suppression by an individual gene is expected to not 
be a complete rescue. 
The second round of data analysis done recently has yielded a list of predicted targets 
perhaps more promising than the last, as each target was identified as enriched within a previous 
ain-2 IP or alg-1 IP (tarbase, Zisoulis et al. 2010) in comparison to the pilot list where this was 
not the case. Between these two data analyses, targets selected for further analysis include hbl-1, 
lin-17, F26A3.4, skn-1, and daf-12. These targets were selected because they are downstream 
within known growth signaling pathways and it is hypothesized that overexpression of these 
targets (caused by loss of specific miRNAs) is causing or contributing to the larval arrest. 
Testing RNAi of these targets with the crosses for suppression, in addition to qRT-PCR 
of the targets to ascertain if mRNA levels of the targets change between the mutants remains to 
be completed. Initial RT-qPCR data with T24B8.5 (an initial target from the first analysis), as a 
previously published test gene (Troemel et al., 2006), remains cursory and in need of further 
replicates. It is expected that mRNA levels of the predicted targets should rise within the 
respective miRNA mutants, as these miRNA should be downregulating these targets normally. 
RT-qPCR should provide another meaningful avenue for approaching the remaining question of 
whether or not these potential targets are actual targets. 
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Together, the miRNA synthetic screen, RNAi data, and data analysis yielding potential 
downstream targets provide interesting clues as to how vigilin and the miRISC are interacting 
together to influence development. Much work remains to be done to further investigate the 
potential targets, however the list presented here provides an ample starting position. Further 
analysis with genetic approaches and RT-qPCR should solidify the interactions of these miRNA 
with specific previously unexplored downstream targets and further our understanding of the 
interactions between vigilin and the microRNA induced silencing complex. 
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  1:	  List	  of	  Strains	  used.	  	  	  	  	  	  	  	  	  	  	  
Strain name Gene Mutant name Strain'Name Gene'Mutant'Name Strain'Name Gene'Mutant'Name
CU8018 miR$34'(gk437) MT14091 mir-79(n4126) MT15312 mir$239a'mir$239'b(nDf62)
DR721 lin-4(e912) II. MT14118 mir$241;'mir$84 MT15454 mir$243(n4759)
MH 4379 Mir-80 MT14119 mir$35$41(nDf50) MT15517 mir$233(n4761)
MH4360 mir$253(nDf64) MT14347 mir$273(n4438) MT15767 mir$258.2
MH4364 fer$15(b26);'ain$1(tm3681) MT14449 mir$232(nDf56) MT15873 Mir$240;'mir$786'(n4541)
MH4368 mir$58(n4640) MT14450 Mir-51 (n4473) MT15982 Mir-67
MH4379 mir$80(nDf53) MT14451 mir-76(n4474) MT15982 mir$67(n4899)
MT12945 mir$52(n4100) MT14452 Mir-46 (n4475) MT16308 mir$252(n4570)
MT12954 Mir-1 MT14525 MIR$254 MT16309 Mir-247 & mir-707 (n4505) X
MT12958 mir$87(n4104) MT14588 mir$234(n4520) MT16310 mir$269(n4641)
MT12969 mir$259(n4106) MT14661 mir$265(n4534) MT16311 mir-77(n4286)
MT12988 MT14662 Mir$230'(n4535) MT16316 mir$355(n4618)
MT12989 Mir-53 (n4113) MT14673 mir$359(n4540) MT16335 mir$251(N4606)
MT12993 mir-71(n4115) MT14682 mir$257(n4548) MT16336 mir$86(n4607)'
MT12999 mir$85(n4117) MT14767 Mir$54;'mir$55 MT16337 mir$245(n4798)
MT13015 mir$72(n4130) MT14768 Mir-231 MT16471 mir$60(n4947)'II.
MT13016 Mir-64; mir-229 (nDf52) MT14875 Mir-61; Mir-250 (nDf875) MT16494 Mir$64$66;'mir$229'(nDf63)'III
MT13016 Mir-64; mir-229 (nDf52) MT14876 mir$261(n4594) MT16696 mir$244(n4367)
MT13078 mir$73$74(nDf47) MT14878 mir$270(n4595) MT16848 mir$249(n4983)'X
MT13292 mir$124(n4255) MT14919 mir$260(n4601) MT17445 mir$62(n4539)'X.
MT13372 Mir$42$44'(nDf49) MT14935 mir$59(n4604) MT17997 mir$235(n4504)
MT13433 Mir-45 (n4280) MT14936 mir$242(n4605) MT18037 mir$75
MT13650 Lin-58;mir-48 MT14993 Mir-46 (n4475) & mir-47 (gk167) MT7626 Let$7
MT13651 Mir-84 MT15018 mir$360(n4635) OH2535 lsy$6(at71)
MT13652 Mir-48; mir-84 MT15019 Mir$357$358(nDf60) VC328 mir$47(gk167)
MT13653 Mir$237 MT15020 mir$246(n4636)'IV VC347 Mir$57
MT13897 Mir-241 MT15021 mir-78(n4637) VC495 mir$2(gk259)
MT13949 mir$80 MT15022 mir$83(n4638) VC514 mir$35(gk262)
MT13954 Mir-81; Mir-82 (nDf54) MT15023 mir$268(n4639) VT1289 mir$63(n4568)'X
MT15024 mir$58 N2'(wild'type)
Ain-2
! Sequence!Name Gene!Name Predicted!Function ! Sequence!Name Gene!Name Predicted!Function ! Sequence!Name Gene!Name Predicted!Function ! Sequence!Name Gene!Name Predicted!Function ! Sequence!Name Gene!Name Predicted!Function
1 B0024.13 Unknown 81 Y42H9B.2 rigB4 Unknown 161 Y45F10D.3 glyB10 Metabolism 241 Y38E10A.12 nspeB3 Unknown 321 F20D1.7 iglrB1 Unknown
2 B0379.4 scplB1 Unknown 82 Y44A6D.3 Unknown 162 B0416.6 glyB13 Metabolism 242 Y43F8C.3 Unknown 322 F32D8.1 Signalling
3 B0454.6 Metabolism 83 Y47H9C.4 cedB1 Signalling 163 C26C6.2 goaB1 Signalling 243 Y48C3A.11 dmsrB3 Unknown 323 F58E10.1 ricB7 Unknown
4 B0564.6 Unknown 84 Y53C12B.5 mabB3 Unknown 164 F13D11.2 hblB1 Transcription!Factor 244 Y106G6H.14 DNABCell!Cycle 324 K09E9.2 ervB46 Unknown
5 C01C7.1 arkB1 Signalling 85 Y54G11A.8 ddlB3 Unknown 165 R13H4.4 hmpB1 Signalling 245 Y111B2A.15 tpstB1 Unknown 325 R10E12.2 Unknown
6 C03E10.4 glyB20 Unknown 86 Y57G11C.11 coqB3 Unknown 166 K07A1.8 ileB1 Unknown 246 ZK757.4 dhhcB4 Unknown 326 T28D6.4 Unknown
7 C04A2.3 eglB27 Chromatin 87 Y60A3A.21 Unknown 167 F26D11.11 letB413 Signalling 247 ZK795.1 Unknown 327 Y54G11A.8 ddlB3 Unknown
8 C04D8.1 pacB1 Unknown 88 Y67D8C.10 mcaB3 Unknown 168 F57B9.2 letB711 Unknown 248 ZK1128.4 RNA!Synthesis 328 C06E1.3 doxaB1 Unknown
9 C05D11.4 letB756 Signalling 89 Y67D8C.9 Unknown 169 C39E6.1 lonB2 Unknown 249 B0238.11 Unknown 329 C24B5.1 Neuro
10 C07D10.4 nasB7 Proteases 90 Y71F9B.8 lronB11 Unknown 170 R03E9.1 mdlB1 Transcription!Factor 250 B0410.3 Unknown 330 C30F12.2 Unknown
11 C08B11.1 zygB11 Unknown 91 ZK370.3 hiprB1 Unknown 171 Y57E12AL.5 mdtB6 Unknown 251 C01F4.2 rgaB6 Unknown 331 C34B2.11 Unknown
12 C13B4.1 Unknown 92 ZK418.7 Neuro 172 R10E9.1 msiB1 RNA!Binding 252 C14C11.3 hexB2 Unknown 332 C34H3.1 tagB275 Unknown
13 C16C8.2 Metabolism 93 ZK682.2 Cell!Arch 173 W04H10.3 nhlB3 Unknown 253 C14F5.4 sfxnB2 Metabolism 333 C54D1.5 lamB2 Cell!Arch
14 C16D9.6 Unknown 94 ZK867.1 sydB9 Unknown 174 E02H1.7 nhrB19 Transcription!Factor 254 C17H12.13 anatB1 Unknown 334 F07C3.4 gloB4 DNABCell!Cycle
15 C23H4.1 cabB1 Neuro 95 C17H12.1 dyciB1 Unknown 175 F11C1.6 nhrB25 Transcription!Factor 255 C26B9.1 Unknown 335 F13H6.1 NA!Binding
16 C24A8.4 cstB2 Unknown 96 C52A11.4 mpzB1 Signalling 176 F48F7.4 pqnB39 Unknown 256 C30A5.3 Unknown 336 F20D6.10 Unknown
17 C30F12.2 Unknown 97 C53B4.3 Unknown 177 F45H7.4 prkB2 Signalling 257 C30H7.2 Metabolism 337 F28E10.2 igegB1 Signalling
18 C33A11.2 Unknown 98 F13D11.2 hblB1 Transcription!Factor 178 R07H5.1 prxB14 Unknown 258 C48E7.1 Unknown 338 F29B9.8 Unknown
19 C34B2.11 Unknown 99 F14E5.5 lipsB10 Unknown 179 ZK675.1 ptcB1 Signalling 259 C55C3.5 permB5 Unknown 339 F42H10.3 Signalling
20 C39E6.1 lonB2 Unknown 100 F47G9.4 Unknown 180 C53C11.3 ptrB5 Signalling 260 EEED8.10 RNA!Binding 340 H10E21.5 Unknown
21 C43F9.8 efnB2 Unknown 101 F53C11.7 swanB2 Unknown 181 F46G10.5 ptrB24 Signalling 261 EGAP2.1 Unknown 341 K07C11.8 Unknown
22 C52E4.5 mansB2 Unknown 102 H13N06.2 Unknown 182 K09E2.4 rigB1 Signalling 262 F07C3.4 gloB4 DNABCell!Cycle 342 M03F8.1 Unknown
23 D1046.5 tpraB1 Unknown 103 K03C7.2 fkhB9 Transcription!Factor 183 ZK20.5 rpnB12 Degradation 263 F13H6.1 NA!Binding 343 R05H11.2 Unknown
24 F07C3.4 gloB4 DNABCell!Cycle 104 K08H10.4 udaB1 Metabolism 184 C18F3.2 saxB7 Signalling 264 F18C5.10 Unknown 344 R12E2.2 Unknown
25 F10C5.2 Degradation 105 R10E12.2 Unknown 185 R12H7.3 skrB19 Degradation 265 F22D3.2 flcnB1 Unknown 345 T23B12.6 Unknown
26 F16A11.1 Unknown 106 T23G4.1 tlpB1 NA!Binding 186 W03G9.1 snfB1 Neuro 266 F28B4.2 rglB1 Signalling 346 Y71F9B.8 lronB11 Unknown
27 F16F9.4 Metabolism 107 Y38F1A.5 cydB1 DNABCell!Cycle 187 Y110A2AL.14 sqvB2 Unknown 267 F28C10.3 Signalling
28 F20B10.1 nlrB1 Signalling 108 Y54E10A.16 mabB31 Unknown 188 C52E12.3 sqvB7 Cell!Arch 268 F28H1.1 Unknown
29 F20G4.3 nmyB2 Cell!Arch 109 Y38F1A.5 cydB1 DNABCell!Cycle 189 ZK1307.5 sqvB8 Metabolism 269 F32B5.7 Unknown
30 F23B12.9 eglB1 Unknown 110 F13D11.2 hblB1 Transcription!Factor 190 F54C9.2 stcB1 Protein!Synthesis 270 F39G3.5 Metabolism
31 F23H12.1 snbB2 Cell!Arch 111 T23G4.1 tlpB1 NA!Binding 191 D1014.1 sulB2 Metabolism 271 F40A3.7 Neuro
32 F25H2.13 rtelB1 DNABCell!Cycle 112 C53B4.3 Unknown 192 T22B2.4 supB12 RNA!Binding 272 F41A4.1 cutlB28 Unknown
33 F26A3.4 Signalling 113 F14E5.5 lipsB10 Unknown 193 K03A1.5 surB5 Metabolism 273 F41H10.5 Proteases
34 F26E4.11 hrdlB1 Degradation 114 F53C11.7 swanB2 Unknown 194 R13A1.2 kccB1 Small!Molecule!Transport 274 F42A10.7 Unknown
35 F28B4.2 rglB1 Signalling 115 H13N06.2 Unknown 195 Y38C1AA.4 tclB2 Unknown 275 F54A3.6 Unknown
36 F28D1.10 gexB3 Signalling 116 K08H10.4 udaB1 Metabolism 196 F39H11.2 tlfB1 RNA!Synthesis 276 F55D10.3 glitB1 Metabolism
37 F29B9.8 Unknown 117 R10E12.2 Unknown 197 T23D8.2 tspB7 Unknown 277 F56H1.5 ccppB1 Unknown
38 F29F11.4 twkB12 Small!Molecule!Transport 118 C17H12.1 dyciB1 Unknown 198 K07B1.3 ucpB4 Metabolism 278 F59A3.2 Unknown
39 F32F2.1 uigB1 Signalling 119 H04M03.4 glfB1 Unknown 199 R12H7.1 uncB9 Cell!Arch 279 F59A3.4 Unknown
40 F35H10.4 vhaB5 Small!Molecule!Transport 120 B0238.11 Unknown 200 Y37E11AR.6 vabB2 Unknown 280 K02E10.1 Cell!Arch
41 F37D6.6 tagB68 Unknown 121 B0410.3 Unknown 201 F20B6.2 vhaB12 Metabolism 281 K05F1.6 Cell!Arch
42 F38E11.7 wrtB3 Neuro 122 B0464.4 breB3 Unknown 202 C01G12.1 madfB5 Unknown 282 M01E11.1 Metabolism
43 F44G4.8 depB1 Signalling 123 C01C7.1 arkB1 Signalling 203 C03C10.4 Unknown 283 M01H9.1 trxB3 Metabolism
44 F45H7.2 geiB1 Signalling 124 C01G12.1 madfB5 Unknown 204 C06G8.1 swtB3 Unknown 284 R05G6.10 Signalling
45 F53B1.8 Small!Molecule!Transport 125 C05C8.7 Metabolism 205 C08H9.1 Proteases 285 T02C5.3 igcmB3 Signalling
46 F54G8.3 inaB1 Cell!Arch 126 C06E7.3 samsB4 Metabolism 206 C16C10.1 Metabolism 286 T02G5.13 mmaaB1 Unknown
47 F58H1.5 Unknown 127 C06G8.1 swtB3 Unknown 207 C39E9.10 Signalling 287 T03F1.1 Unknown
48 F59B2.2 Small!Molecule!Transport 128 C10B5.3 Unknown 208 C53B4.6 nstpB1 Unknown 288 T05A7.1 Unknown
49 H03A11.1 Unknown 129 C13G3.1 Unknown 209 E02A10.4 Unknown 289 T19A5.1 Unknown
50 H10E21.5 Unknown 130 C17H12.13 anatB1 Unknown 210 F11A5.9 Cell!Arch 290 T24H7.3 Unknown
51 H12C20.2 pmsB2 DNABCell!Cycle 131 C18A3.2 Unknown 211 F11A10.6 Unknown 291 W04B5.5 Signalling
52 K02F2.6 serB3 Neuro 132 C26B9.1 Unknown 212 F21G4.1 Proteases 292 W06B11.1 atatB2 Unknown
53 K07G5.1 crmlB1 Unknown 133 D1014.4 Unknown 213 F25H9.6 Metabolism 293 Y37E11B.6 Unknown
54 K08E3.4 Cell!Arch 134 F08C6.1 adtB2 Proteases 214 F28D1.9 acsB20 Metabolism 294 Y43H11AL.1 Unknown
55 K08H10.7 rdeB1 RNA!Binding 135 F09E10.3 dhsB25 Metabolism 215 F36H2.1 tatB5 Small!Molecule!Transport 295 Y49G5B.1 Unknown
56 M01F1.4 Unknown 136 F13H6.1 NA!Binding 216 F37A8.5 Unknown 296 Y55B1AL.1 Unknown
57 M110.5 dabB1 Signalling 137 F16B4.8 cdcB25.2 DNABCell!Cycle 217 F44G4.8 depB1 Signalling 297 Y59H11AR.2 catpB7 Unknown
58 M28.6 lactB3 Unknown 138 F17C11.3 colB153 Collagen 218 F46G10.2 Unknown 298 Y97E10AR.2 Unknown
59 R08C7.12 Unknown 139 F17C8.1 acyB1 Signalling 219 F53E4.1 Unknown 299 R11B5.1 tbcB12 Cell!Arch
60 R10E12.2 Unknown 140 F17E5.2 Metabolism 220 F55H2.7 Unknown 300 C33H5.19 tagB321 Unknown
61 R13H8.1 dafB16 Transcription!Factor 141 F18C5.10 Unknown 221 F56H11.2 Unknown 301 T14B1.2 aexB2 Neuro
62 T03F6.4 Unknown 142 F20D1.1 Unknown 222 F59B2.2 Small!Molecule!Transport 302 C01C7.1 arkB1 Signalling
63 T07F12.2 Unknown 143 F25B3.1 ehbpB1 Cell!Arch 223 H13N06.2 Unknown 303 C23H4.1 cabB1 Neuro
64 T13H5.6 Unknown 144 F25F2.2 cdhB4 Signalling 224 K08E3.4 Cell!Arch 304 Y38F1A.5 cydB1 DNABCell!Cycle
65 T22D1.8 Unknown 145 F26A1.6 Unknown 225 K08H10.4 udaB1 Metabolism 305 F23B12.9 eglB1 Unknown
66 T23B12.6 Unknown 146 K08F8.2 atfB2 Transcription!Factor 226 K09A9.6 Unknown 306 R10E9.1 msiB1 RNA!Binding
67 T24C4.6 zerB1 Unknown 147 T07F10.4 busB19 Unknown 227 K09E9.2 ervB46 Unknown 307 C07D10.4 nasB7 Proteases
68 T27F7.2 shcB2 Signalling 148 Y108G3AL.1 culB3 Unknown 228 R03A10.4 nkatB3 Metabolism 308 E02H1.7 nhrB19 Transcription!Factor
69 T28B11.1 Degradation 149 Y65B4BL.5 acsB13 Unknown 229 R90.1 Signalling 309 ZK270.1 ptrB23 Signalling
70 T28C12.4 Metabolism 150 F17C8.1 acyB1 Signalling 230 T04F3.2 Unknown 310 Y42H9B.2 rigB4 Unknown
71 T28D6.4 Unknown 151 F08C6.1 adtB2 Proteases 231 T05H10.7 Unknown 311 K02F2.6 serB3 Neuro
72 T28F3.3 hkeB4.1 Unknown 152 B0464.4 breB3 Unknown 232 T13H5.1 Signalling 312 F23H12.1 snbB2 Cell!Arch
73 W01G7.1 dafB5 Unknown 153 F25F2.2 cdhB4 Signalling 233 T21B10.6 cutlB15 Unknown 313 ZC404.8 spnB4 RNA!Binding
74 W03G9.1 snfB1 Neuro 154 C07H6.5 cghB1 RNA!Binding 234 T21C9.4 Unknown 314 Y38C1AA.4 tclB2 Unknown
75 W10D5.1 mefB2 Transcription!Factor 155 C01C10.1 clcB2 Unknown 235 T23F11.3 cdkaB1 Unknown 315 T24A11.3 tohB1 Proteases
76 Y14H12A.1 Unknown 156 F42G9.2 cynB6 Metabolism 236 T24B8.4 Unknown 316 Y71A12B.4 trpB4 Unknown
77 Y22D7AR.13 serB4 Unknown 157 C01F6.4 femB3 RNA!Synthesis 237 T24B8.5 Unknown 317 F35H10.4 vhaB5 Small!Molecule!Transport
78 Y37E11AR.6 vabB2 Unknown 158 T07D1.4 foxB1 RNA!Binding 238 W02A11.3 toeB4 Unknown 318 B0336.1 wrmB1 Signalling
79 Y38F1A.5 cydB1 DNABCell!Cycle 159 C51F7.1 frmB7 Unknown 239 W09D6.5 Unknown 319 F38E11.7 wrtB3 Neuro
80 Y40H4A.1 garB3 Neuro 160 T22H6.6 geiB3 Chromatin 240 W09G3.6 Unknown 320 C13B4.1 Unknown
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  Supplemental	  Table	  2:	  1st	  List	  of	  predicted	  miRNA(-­‐)	  targets	  and	  predicted	  function.	  
Supplemental	  Table	  3:	  2nd	  list	  of	  predicted	  miRNA	  targets	  and	  associated	  Dicer	  microarray	  and	  Gut	  IP	  enrichment.	  	  
Mir$83 Sequence Gene 60 C04E6.7 116 C09D8.1 ptp.3 176 F55C12.1 232 W08D2.1 egl.20 292 C54G10.4 352 C06G1.1
1 C23H4.1 cab.1 61 C06G1.4 ain.1 117 F53G12.1 rab.11.1 177 F56C9.8 233 Y40H4A.1 gar.3 293 F01D5.10 353 C16D9.6
2 F25F2.2 cdh.4 62 C16A3.2 118 C05B5.7 rgs.1 178 H34C03.2 234 F28D1.10 gex.3 294 F11E6.3 354 C23H3.2
3 F46C8.5 ceh.14 63 C34H3.1 tag.275 119 C18F3.2 sax.7 179 K07H8.2 235 ZC308.1 gld.2 295 F11E6.8 355 C26B9.1
4 ZC64.3 ceh.18 64 C42C1.4 120 H20J18.1 scd.1 180 R01B10.5 jamp.1 236 B0416.6 gly.13 296 F14E5.2 356 C31H1.8
5 T25F10.2 dbl.1 65 C45E5.4 121 F57C7.3 sdn.1 181 R12E2.2 237 C03E10.4 gly.20 297 F16A11.1 357 C49H3.9
6 C56C10.13 dnj.8 66 C53D5.1 122 F35G12.3 sel.5 182 T07E3.6 pdf.1 238 C18A3.8 hlh.14 298 F21A3.3 358 C53D5.1
7 K09G1.4 dop.2 67 F42H10.3 123 W03G9.1 snf.1 183 T07F12.2 239 C16E9.4 inx.1 299 F25D7.2 tag.353 359 C56C10.11
8 C26D10.5 eff.1 68 H18N23.2 124 T01G5.3 srj.27 184 T22F3.3 240 K11D9.1 klp.7 300 F26A3.4 360 C56E6.6 lron.15
9 F35D6.1 fem.1 69 K02E10.1 125 F35B12.1 srx.84 185 T24H7.3 241 C01G8.9 let.526 301 F26E4.11 hrdl.1 361 CC8.2
10 F56A11.1 gex.2 70 R05C11.3 mca.2 126 R03E1.1 sym.4 186 T26A5.5 jhdm.1 242 C05D11.4 let.756 302 F31C3.3 362 F13H8.11
11 C03E10.4 gly.20 71 T28D9.7 del.10 127 F44A2.1 tag.153 187 W02C12.3 hlh.30 243 F36H1.4 lin.3 303 F40F12.5 cyld.1 363 F18A12.8 nep.11
12 C16E9.4 inx.1 72 W08A12.1 unc.132 128 R13A1.2 kcc.1 188 Y39G10AR.18 244 Y71F9B.5 lin.17 304 F44G4.8 dep.1 364 F21A9.2
13 C05D11.4 let.756 73 Y34D9A.2 npr.23 129 C07A9.3 tlk.1 189 Y51F10.7 245 M04B2.1 mep.1 305 F45D3.3 365 F21F3.6
14 W06F12.1 lit.1 74 Y73B6BL.6 sqd.1 130 T23G4.1 tlp.1 190 Y59E9AL.4 246 R07E4.4 mig.23 306 F45D3.4 366 F41C3.2
15 ZK112.2 ncl.1 131 F39C12.3 tsp.14 191 Y71H2AM.5 247 T20B12.6 mml.1 307 F46C5.1 367 F44A2.3
16 F25G6.6 asns.1 miR$59 Sequence Gene 132 C47E12.5 uba.1 192 ZK418.7 248 F46G10.6 mxl.3 308 F46G10.2 368 F49H12.6 acl.4
17 T21D12.4 pat.6 75 F44E5.1 133 Y54E10A.9 vbh.1 249 K08E5.2 nac.3 309 F52D10.2 369 F52F10.2
18 T27B1.2 pat.9 76 H19N07.1 erfa.3 134 C04C11.2 arrd.25 miR$265 Sequence Gene 250 C07D10.4 nas.7 310 F58H1.5 370 F53B1.2
19 T14F9.4 peb.1 77 R107.5 135 C05C12.6 193 C01G6.5 251 C02B4.2 nhr.17 311 F59B2.13 371 F57F10.1 abts.3
20 W01C9.3 pqn.73 78 T21C9.3 del.6 136 C07A9.9 194 C18E9.2 252 E02H1.7 nhr.19 312 H03A11.1 372 F59G1.1 cgt.3
21 C48D5.2 ptp.1 79 T24B8.3 137 C13G3.1 195 C34B4.2 253 C01H6.5 nhr.23 313 H27A22.1 373 K03E6.7
22 F53G12.1 rab.11.1 80 W02B12.9 mfn.1 138 C17G1.4 nra.3 196 C37E2.1 idhb.1 254 C07A12.3 nhr.35 314 K01B6.1 fozi.1 374 M01B12.4
23 K01G5.6 rib.2 81 Y17G7B.20 139 C34E11.2 197 F26A3.4 255 C45E5.6 nhr.46 315 K01D12.6 375 R01B10.5 jamp.1
24 F18C12.2 rme.8 82 B0041.5 140 DH11.5 198 F45D3.3 256 T09A12.4 nhr.66 316 K07A12.2 egg.6 376 R05G6.10
25 F57C7.3 sdn.1 83 C06A8.3 141 F09B12.3 199 F47G4.4 257 F20B10.1 nlr.1 317 K08E4.3 377 R12C12.3 frpr.16
26 F15C11.1 sem.4 84 C06E7.1 sams.3 142 F14B4.3 rpoa.2 200 F58E10.1 ric.7 258 C07G1.3 pct.1 318 K10D6.4 378 T01A4.1 gcy.28
27 C14F5.5 sem.5 85 C06E7.4 143 F17C11.9 eef.1G 201 H36L18.2 259 T14F9.4 peb.1 319 M88.5 zbp.1 379 T06F4.1
28 T10H9.4 snb.1 86 C16A3.10 144 F31D4.8 202 T21C9.3 del.6 260 C09D8.1 ptp.3 320 R08D7.6 pde.2 380 T07F12.2
29 W03G9.1 snf.1 87 C32F10.8 145 F39B2.1 203 T27D12.1 261 C54A12.1 ptr.6 321 R10E12.2 381 T19A5.1
30 F21F8.10 str.135 88 D1009.1 acs.22 146 F55H2.2 vha.14 204 T28F4.5 262 Y38F1A.3 ptr.18 322 R13H4.5 382 T27E4.7
31 K02E10.8 syg.1 89 F13H6.1 147 F57G12.1 205 Y39A1A.9 263 C18F3.2 sax.7 323 R107.5 383 W02C12.3 hlh.30
32 F39C12.3 tsp.14 90 F21F3.6 148 T05D4.1 aldo.1 206 ZK131.11 264 Y22D7AR.13 ser.4 324 T02E9.1 npr.25 384 Y39A3B.2 lgc.42
33 F41C6.1 unc.6 91 F23F12.12 149 T05H10.7 207 B0361.9 265 T19E7.2 skn.1 325 T04F3.2 385 Y58A7A.6 glb.32
34 F14D12.2 unc.97 92 F35H10.10 150 T12G3.2 208 C30G4.7 266 Y51A2D.19 slo.1 326 T05B9.2 386 Y61A9LA.1
35 F09B9.2 unc.115 93 K07B1.8 151 T14B1.1 209 C48A7.2 pitr.1 267 F35G12.8 smc.4 327 T07F10.1 387 Y65B4BL.5 acs.13
36 Y54E10A.9 vbh.1 94 K08D12.6 152 T24B8.4 210 D1009.1 acs.22 268 Y22D7AL.8 sms.3 328 T12G3.2 388 Y67D8C.9
37 Y53C12A.1 wee.1.3 95 R151.2 153 T25E12.4 dkf.2 211 F35H10.10 269 AC7.2 soc.2 329 T13H5.6 389 Y71D11A.5 lgc.46
38 B0344.2 wrt.9 96 Y73B6BL.24 acp.6 154 W08D2.5 catp.6 212 F36D4.5 270 C09H6.1 spr.4 330 T24B8.4 390 Y71H2AL.2
39 F28F9.1 zag.1 155 Y11D7A.13 flh.3 213 K04F10.3 271 F54C9.2 stc.1 331 T24C2.5 391 Y73E7A.3
40 C01G12.1 madf.5 miR$254 Sequence Gene 156 Y45F10D.2 214 K09H9.7 272 F12F6.5 srgp.1 332 W01F3.1 392 Y102A11A.8 igcm.4
41 C03C10.4 97 B0464.4 bre.3 157 Y49E10.11 tat.1 215 R04E5.8 273 B0222.4 tag.38 333 W03C9.5 393 ZK154.6
42 C17E4.10 98 F11C7.4 crb.1 158 Y57A10B.1 42068 216 R05D3.2 274 F37D6.6 tag.68 334 W04G3.2 lpr.5 394 ZK355.2
43 C33A11.2 99 F11A1.3 daf.12 159 Y76A2B.5 217 T27E4.7 275 T23G4.1 tlp.1 335 Y48C3A.4 ztf.22 395 ZK418.7
44 F01D5.10 100 C43C3.3 dyf.7 160 ZK1037.3 srt.22 218 ZK370.4 276 F29F11.4 twk.12 336 Y57G11C.31 396 ZK682.2
45 F13E9.1 101 C02C6.1 dyn.1 161 B0336.3 277 F25H2.8 ubc.25 337 Y64G10A.6
46 F21A3.3 102 T01H8.5 gon.2 162 C10G6.1 egal.1 miR$52 Sequence Gene 278 Y37E11AR.6 vab.2 338 ZC84.3 cls.3
47 F43D9.1 103 F13D11.2 hbl.1 163 C13F10.4 219 F31A3.1 abu.3 279 F08B1.1 vhp.1 339 ZC376.7 atfs.1
48 H19N07.2 math.33 104 C49H3.10 xpo.3 164 C26F1.6 frpr.3 220 F17C8.1 acy.1 280 C46C2.1 wnk.1 340 ZK131.11
49 K09E9.2 erv.46 105 R07E4.6 kin.2 165 C30B5.7 221 F08C6.1 adt.2 281 F38E11.7 wrt.3 341 ZK673.2
50 R07B1.9 106 F58H12.1 kin.29 166 C35A11.1 dmsr.7 222 F25F2.2 cdh.4 282 C08B11.1 zyg.11 342 ZK1321.2 shk.1
51 T04F3.2 107 F36H1.4 lin.3 167 C42C1.4 223 F56D1.4 clr.1 283 B0024.14 crm.1 343 D2023.1
52 T07F10.4 bus.19 108 T12F5.4 lin.59 168 C43G2.1 paqr.1 224 F11C7.4 crb.1 284 B0334.6 344 B0034.1
53 T23F11.3 cdka.1 109 T24A11.1 mtm.3 169 C48A7.2 pitr.1 225 K10B4.6 cwn.1 285 B0491.1 345 B0410.2 vang.1
54 T24B8.4 110 C10G8.5 ncx.2 170 CC8.2 226 T25F10.2 dbl.1 286 C03C10.4 346 B0410.3
55 W01F3.1 111 T09A12.4 nhr.66 171 F21A9.2 227 C18D1.1 die.1 287 C06G8.1 swt.3 347 B0454.6
56 Y11D7A.13 flh.3 112 D2005.2 nlp.8 172 F26F12.3 228 F54D5.8 dnj.13 288 C08B11.3 swsn.7 348 C01F1.6
57 Y38H6C.14 113 F35C8.6 pfn.2 173 F31A3.5 229 C26D10.5 eff.1 289 C18E9.7 349 C04D8.1 pac.1
58 Y41E3.1 114 E01H11.1 pkc.2 174 F32B5.6 230 C43F9.8 efn.2 290 C29A12.4 nrx.1 350 C05D11.7
59 Y45F10D.2 115 F55A12.3 ppk.1 175 F52G3.1 231 C08C3.1 egl.5 291 C35C5.6 351 C06E1.3 doxa.1
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